These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36600126)

  • 41. Pre-treatment total metabolic tumour volumes in lymphoma: Does quantity matter?
    El-Galaly TC; Villa D; Cheah CY; Gormsen LC
    Br J Haematol; 2022 Apr; 197(2):139-155. PubMed ID: 35037240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total tumor burden in lymphoma - an evolving strong prognostic parameter.
    Meignan M; Cottereau AS; Specht L; Mikhaeel NG
    Br J Radiol; 2021 Nov; 94(1127):20210448. PubMed ID: 34379496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
    Leccisotti L; Maccora D; Malafronte R; D'Alò F; Maiolo E; Annunziata S; Rufini V; Giordano A; Hohaus S
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2783-2791. PubMed ID: 35779106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional Parameters of
    Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
    Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 11 automated PET segmentation methods in lymphoma.
    Weisman AJ; Kieler MW; Perlman S; Hutchings M; Jeraj R; Kostakoglu L; Bradshaw TJ
    Phys Med Biol; 2020 Nov; 65(23):235019. PubMed ID: 32906088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma.
    Kitadate A; Narita K; Fukumoto K; Terao T; Tsushima T; Kobayashi H; Abe Y; Miura D; Takeuchi M; Machida Y; Matsue K
    Cancer Med; 2020 Aug; 9(15):5509-5518. PubMed ID: 32558387
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.
    Wight J; Wai SH; Shen E; Lee ST; Berlangieri S; Fancourt T; Hawkes E; Hannah A; Leung T; Chong G
    Eur J Haematol; 2021 Oct; 107(4):475-483. PubMed ID: 34240453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumour necrosis as assessed with
    Kahle XU; Hovingh M; Noordzij W; Seitz A; Diepstra A; Visser L; van den Berg A; van Meerten T; Huls G; Boellaard R; Kwee TC; Nijland M
    Eur Radiol; 2019 Nov; 29(11):6018-6028. PubMed ID: 31028445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
    Woff E; Hendlisz A; Ameye L; Garcia C; Kamoun T; Guiot T; Paesmans M; Flamen P
    J Nucl Med; 2019 Feb; 60(2):178-184. PubMed ID: 29959212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Baseline [
    Yang Q; Luo Y; Zhang Y; Zhang W; Zhou D; Li F
    Eur Radiol; 2022 Aug; 32(8):5568-5576. PubMed ID: 35316362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. To Determine the Prognostic Significance of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan-Derived Parameters (Total Lesion Glycolysis and Metabolic Tumor Volume) in Patients of Diffuse Large B-Cell Lymphoma with Only Nodal Involvement.
    Gupta N; Singh N
    Indian J Nucl Med; 2020; 35(2):100-104. PubMed ID: 32351262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders.
    Parghane RV; Basu S
    PET Clin; 2022 Jul; 17(3):465-478. PubMed ID: 35717102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network.
    Han S; Oh JS; Kim YI; Seo SY; Lee GD; Park MJ; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Clin Nucl Med; 2022 Jul; 47(7):590-598. PubMed ID: 35675135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma.
    Terao T; Machida Y; Narita K; Kuzume A; Tabata R; Tsushima T; Miura D; Takeuchi M; Tateishi U; Matsue K
    Eur Radiol; 2021 Aug; 31(8):6136-6144. PubMed ID: 33496828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Semiautomatic and Deep Learning-Based Fully Automatic Segmentation Methods on [
    Constantino CS; Leocádio S; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz S; Teixeira R; Neves M; Lúcio P; João C; Costa DC
    J Digit Imaging; 2023 Aug; 36(4):1864-1876. PubMed ID: 37059891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of
    Yang J; Yan J; Li J; Yang Z; Zhang H; Zhao Q; Xu W
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):91-99. PubMed ID: 35292144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prognostic Value of
    Su JM; Zheng QZ; Huang WR; Deng J; Wu J; Lu HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1181-1186. PubMed ID: 34362500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Association Between Liver and Tumor [
    Wu X; Bhattarai A; Korkola P; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    Mol Imaging Biol; 2017 Oct; 19(5):787-794. PubMed ID: 28144908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.